Cite
HARVARD Citation
Zhu, T. et al. (2022). Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF‐07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS‐CoV‐2, in Healthy Adult Participants. Clinical pharmacology in drug development. 11 (12), pp. 1382-1393. [Online].